Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes

INTRODUCTION: The presence of tumor-infiltrating lymphocytes (TILs) is correlated with good prognosis and outcome after (immuno)therapy in triple-negative and HER2-positive breast cancer. However, the role of TILs in luminal breast cancer is less clear. Emerging evidence has now demonstrated that ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobral-Leite, Marcelo, Salomon, Izhar, Opdam, Mark, Kruger, Dinja T., Beelen, Karin J., van der Noort, Vincent, van Vlierberghe, Ronald L. P., Blok, Erik J., Giardiello, Daniele, Sanders, Joyce, Van de Vijver, Koen, Horlings, Hugo M., Kuppen, Peter J. K., Linn, Sabine C., Schmidt, Marjanka K., Kok, Marleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686400/
https://www.ncbi.nlm.nih.gov/pubmed/31391067
http://dx.doi.org/10.1186/s13058-019-1176-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686400/
https://www.ncbi.nlm.nih.gov/pubmed/31391067
http://dx.doi.org/10.1186/s13058-019-1176-2

Ejemplares similares